Takeda Pharmaceutical (TAK) Tax Rate (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded quarterly Tax Rate of 53.78% in Q1 2026, up 300.07% quarter-over-quarter from 26.88% in Q4 2025, and up 7525.0% on a YoY basis from 0.71% in Q1 2025.
Takeda Pharmaceutical (TAK) Tax Rate (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Tax Rate history runs 10 years deep, the most recent figure standing at 53.78% for Q1 2026.
- In Q1 2026, Tax Rate rose 7525.0% year-over-year to 53.78%; the TTM figure through Mar 2026 stood at 27.18% (down 365.0% YoY), while the FY2026 annual figure was 26.2%, down 1204.0% from the prior year.
- Tax Rate was 53.78% for Q1 2026 at Takeda Pharmaceutical, up from 26.88% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 290.99% in Q1 2024 to a low of 38.25% in Q1 2022.
- Historically, Tax Rate has averaged 0.04% across 5 years, with a median of 24.11% in 2023.
- The sharpest annual moves came in 2024 and 2025: Tax Rate jumped 32347 bps in 2024, then plunged 31246 bps in 2025.
- A 5-year view of Tax Rate shows it stood at 11.2% in 2022, then slumped by 315 bps to 24.11% in 2023, then retreated by 19 bps to 28.62% in 2024, then gained by 6 bps to 26.88% in 2025, then jumped by 300 bps to 53.78% in 2026.
- The last three Tax Rate figures came in at 53.78% (Q1 2026), 26.88% (Q4 2025), and 22.47% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 15.33% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.71% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 13.63% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -20.44% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 19.81% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 34.48% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -7.43% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 9.29% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 24.29% |
| 10 | Takeda Pharmaceutical | 169,609.19 | -6.60 Bn | 4.39 Bn | 53.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.78% |
| Mar 31, 2026 | 53.78% |
| Dec 31, 2025 | -26.88% |
| Dec 31, 2025 | -26.88% |
| Sep 30, 2025 | -22.47% |
| Sep 30, 2025 | -22.47% |
| Jun 30, 2025 | -28.17% |
| Jun 30, 2025 | -28.17% |
| Mar 31, 2025 | -21.47% |
| Mar 31, 2025 | -21.47% |
| Dec 31, 2024 | -28.62% |
| Dec 31, 2024 | -28.62% |
| Sep 30, 2024 | -22.47% |
| Sep 30, 2024 | -22.47% |
| Jun 30, 2024 | -30.24% |
| Jun 30, 2024 | -30.24% |
| Mar 31, 2024 | 290.99% |
| Mar 31, 2024 | 290.99% |
| Dec 31, 2023 | -24.11% |
| Dec 31, 2023 | -24.11% |